19

Regional Update 2 Financial Report 3 Governance Report 4

Embed Size (px)

Citation preview

Page 1: Regional Update 2 Financial Report 3 Governance Report 4
Page 2: Regional Update 2 Financial Report 3 Governance Report 4

2

Regional Update

Page 3: Regional Update 2 Financial Report 3 Governance Report 4

3

Financial Report

Page 4: Regional Update 2 Financial Report 3 Governance Report 4

4

Governance Report

Page 5: Regional Update 2 Financial Report 3 Governance Report 4

5

Dr. Joel PachterProgressive MS Update

Page 6: Regional Update 2 Financial Report 3 Governance Report 4

Leukocytes enter the CNS during neuroinflammation

Page 7: Regional Update 2 Financial Report 3 Governance Report 4

The blood-brain barrier is damaged during EAE/MS

Page 8: Regional Update 2 Financial Report 3 Governance Report 4

8

Urgent Need to Find Solutions for People with Progressive MS

•Large worldwide impact: about half of all MS patients

•Finding solutions for progressive MS is one of the top priorities for patients

•Currently paucity of effective DMT for progressive forms of MS

•Every time another therapy is approved for RRMS, a large proportion of our constituents feel left behind

Page 9: Regional Update 2 Financial Report 3 Governance Report 4

9

Society Research Priorities

1. To better understand the biological basis for disease progression

2. To dissect the mechanisms of nerve damage and repair

3. To identify risk and triggering factors for MS

4. To enable development of new or improved rehabilitation techniques

5. To grow the global MS research enterprise

$46 million in current commitments to progressive MS research

Page 10: Regional Update 2 Financial Report 3 Governance Report 4

10

Progressive MS Research Initiatives

1. Over 100 investigator initiated research projects

2. MS Outcomes Assessment Consortium

3. Clinical Trials- MS SMART, SPRINT MS

4. SUMMIT natural history and risk factors study

5. Revision of Lublin-Reingold Clinical Course Descriptor

6. International Progressive MS Alliance

Page 11: Regional Update 2 Financial Report 3 Governance Report 4

Mission

To expedite the development of effective disease modifying and symptom management therapies for progressive forms of multiple sclerosis

Page 12: Regional Update 2 Financial Report 3 Governance Report 4
Page 13: Regional Update 2 Financial Report 3 Governance Report 4
Page 14: Regional Update 2 Financial Report 3 Governance Report 4

Better extravasating of hES-MSC

Page 15: Regional Update 2 Financial Report 3 Governance Report 4

Where is MS research going?

Novel drugs that act on “special” targets (e.g., CCL2)

Stem cell therapy with multifunctional “reparative” rather “replacement” cells

Riluzole – sodium channel blockerAmiloride – diuretic/neuroprotectiveIbudilast – anti-inlfammatory/neuroprotective

Page 16: Regional Update 2 Financial Report 3 Governance Report 4

16

• What FDA approved medications can we expect for secondary progressive MS, and when?

• When will oral therapies be available for progressive MS?

• I see your major research interests are blood brain barrier & neuroinflammation. How do you feel about these as treatment options? What do you suggest we look for when searching for a doctor to treat this?

Q&AMedications & Treatments

Page 17: Regional Update 2 Financial Report 3 Governance Report 4

17

• How soon are we going to see expansion of the stem cell clinical trials?

• Are clinical trails for stem cells taking place in the US?

• Will stem cell therapy become available and if so how would this therapy help any type of MS?

Q&AStem Cells

Page 18: Regional Update 2 Financial Report 3 Governance Report 4

18

• What are the prospects for remylination?

• What progress has been made in RESTORING function, especially in patients who've had MS 20 years?

Q&ARestoring Function

Page 19: Regional Update 2 Financial Report 3 Governance Report 4

19

• What is the difference between the different types of MS? My daughter was recently diagnosed.

• As an undergraduate student starting to study MS, where is the best place to start?

• Will there ever be a cure for MS?

• Is it common for Parkinsons Disease and MS to occur in the same person? Is research being done around this?

Q&AGeneral